Itron (NASDAQ:ITRI) Upgraded to Buy at Johnson Rice

Itron (NASDAQ:ITRI) was upgraded by equities researchers at Johnson Rice from an “accumulate” rating to a “buy” rating in a report released on Monday, MarketBeat reports. The brokerage presently has a $130.00 price objective on the scientific and technical instruments company’s stock. Johnson Rice’s price objective would suggest a potential upside of 35.51% from the company’s previous close.

Several other research analysts have also recently commented on ITRI. Argus reaffirmed a “hold” rating on shares of Itron in a report on Tuesday, November 4th. Robert W. Baird restated a “neutral” rating and set a $118.00 price objective (down previously from $137.00) on shares of Itron in a research report on Friday, October 31st. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Itron in a research note on Monday, December 29th. Baird R W downgraded Itron from a “strong-buy” rating to a “hold” rating in a report on Friday, October 31st. Finally, Stephens upgraded shares of Itron from an “equal weight” rating to an “overweight” rating and set a $130.00 price target for the company in a report on Monday, November 3rd. Nine analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $138.10.

Itron Stock Up 1.5%

Shares of NASDAQ ITRI traded up $1.46 during trading hours on Monday, hitting $95.93. The company had a trading volume of 64,855 shares, compared to its average volume of 213,292. The company has a quick ratio of 1.91, a current ratio of 2.17 and a debt-to-equity ratio of 0.46. The firm’s 50 day moving average is $100.51 and its 200-day moving average is $118.27. The stock has a market capitalization of $4.39 billion, a P/E ratio of 17.25, a price-to-earnings-growth ratio of 0.53 and a beta of 1.49. Itron has a 1-year low of $90.11 and a 1-year high of $142.00.

Itron (NASDAQ:ITRI) last announced its quarterly earnings results on Thursday, October 30th. The scientific and technical instruments company reported $1.54 earnings per share for the quarter, topping analysts’ consensus estimates of $1.48 by $0.06. The firm had revenue of $581.63 million for the quarter, compared to the consensus estimate of $578.49 million. Itron had a return on equity of 17.82% and a net margin of 10.69%.The business’s revenue was down 5.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.84 earnings per share. Itron has set its FY 2025 guidance at 6.840-6.940 EPS and its Q4 2025 guidance at 2.150-2.250 EPS. On average, analysts expect that Itron will post 5.33 earnings per share for the current fiscal year.

Insider Buying and Selling at Itron

In other Itron news, SVP Justin K. Patrick sold 379 shares of the business’s stock in a transaction on Monday, November 24th. The stock was sold at an average price of $96.51, for a total value of $36,577.29. Following the transaction, the senior vice president owned 20,382 shares of the company’s stock, valued at approximately $1,967,066.82. The trade was a 1.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Donald L. Reeves III sold 536 shares of the firm’s stock in a transaction on Monday, November 24th. The shares were sold at an average price of $96.51, for a total value of $51,729.36. Following the sale, the senior vice president directly owned 19,068 shares of the company’s stock, valued at approximately $1,840,252.68. This represents a 2.73% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 2,971 shares of company stock valued at $286,731 in the last ninety days. 1.51% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Itron

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ITRI. Mirabella Financial Services LLP bought a new stake in shares of Itron in the third quarter valued at approximately $226,000. Tudor Investment Corp ET AL lifted its position in shares of Itron by 47.2% during the third quarter. Tudor Investment Corp ET AL now owns 274,644 shares of the scientific and technical instruments company’s stock worth $34,210,000 after acquiring an additional 88,029 shares in the last quarter. Swiss Life Asset Management Ltd lifted its position in shares of Itron by 0.8% during the third quarter. Swiss Life Asset Management Ltd now owns 111,772 shares of the scientific and technical instruments company’s stock worth $13,922,000 after acquiring an additional 874 shares in the last quarter. CIBC Private Wealth Group LLC boosted its holdings in shares of Itron by 7.2% in the third quarter. CIBC Private Wealth Group LLC now owns 4,251 shares of the scientific and technical instruments company’s stock worth $530,000 after acquiring an additional 287 shares during the period. Finally, CIBC Bancorp USA Inc. purchased a new position in shares of Itron in the third quarter valued at $604,000. Institutional investors own 96.19% of the company’s stock.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.